These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4089014)

  • 41. [On the meaning of psychometrically operationalized therapeutic effects in the treatment of brain insufficiency phenomena caused by old age demonstrated by the "Nürnberger-Alters-Inventar" (author's transl)].
    Oswald WD; Matejcek M; Lukaschek K; Dennler HJ; Oswald B
    Arzneimittelforschung; 1982; 32(5):584-90. PubMed ID: 7201839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Usefulness of piracetam in intensive care.
    Godard JP; Goerens C; Grelier C
    Acta Anaesthesiol Belg; 1976; 27 suppl():115-22. PubMed ID: 1015210
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effectiveness of piracetam in tardive dyskinesia - double-blind cross-over controlled trial with a placebo].
    Kabes J; Sikora J; Starý O; Pisvejc J; Hanzlícek L
    Cesk Psychiatr; 1983 Oct; 79(5):339-45. PubMed ID: 6357509
    [No Abstract]   [Full Text] [Related]  

  • 44. The clinical use of piracetam, a new nootropic drug. The treatment of symptoms of senile involution.
    Stegink AJ
    Arzneimittelforschung; 1972 Jun; 22(6):975-7. PubMed ID: 4559159
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of piracetam on cerebral hemodynamics in patients with arteriosclerosis and dyscirculatory encephalopathy].
    Vesel'skiĭ ISh; Voroniuk MI
    Klin Med (Mosk); 1986 Jun; 64(6):41-4. PubMed ID: 3747435
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical studies with piracetam].
    Eckmann F
    MMW Munch Med Wochenschr; 1976 Jul; 118(29-30):957-8. PubMed ID: 820987
    [No Abstract]   [Full Text] [Related]  

  • 47. [Evaluation of the therapeutic effectiveness of a piracetam plus dihydroergocristine combination in the treatment of vertigo].
    López Martínez R
    Acta Otorrinolaringol Esp; 1988; 39(4):287-8. PubMed ID: 3152560
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effectiveness of parenteral administration of piracetam in acute and chronic consciousness disorders in cerebral arteriosclerosis].
    Sobczyk W
    Neurol Neurochir Pol; 1980; 14(2):177-82. PubMed ID: 6993975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The use of lucetam for improvement of cognitive functions in chronic cerebrovascular insufficiency (clinical and encephalographic study)].
    Bugrova SG; Novikov AE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(4):44-8. PubMed ID: 18379503
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A comparative study of noopept and piracetam in the treatment of mild and moderate cognitive impairment in patients with organic brain diseases of vascular and traumatic origin].
    Neznamov GG; Teleshova ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):33-42. PubMed ID: 18697252
    [No Abstract]   [Full Text] [Related]  

  • 51. [Use of Kalicor in the treatment of psycho-organic syndrome].
    Jovicić A; Miljanović B; Preradović M; Nikić S
    Vojnosanit Pregl; 1979; 36(4):284-6. PubMed ID: 506152
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of alcohol organic mental disorder with piracetam.
    Barnas C; Miller C; Gunther V; Fleischhacker WW
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(6):729-37. PubMed ID: 3326044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of piracetam in Huntington's chorea.
    Destée A; Petit H; Warot P
    Eur Neurol; 1984; 23(2):89-91. PubMed ID: 6233148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High versus low-dose piracetam in alcohol organic mental disorder: a placebo controlled study.
    Barnas C; Miller C; Ehrmann H; Schett P; Günther V; Fleischhacker WW
    Psychopharmacology (Berl); 1990; 100(3):361-5. PubMed ID: 2179979
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Efficacy and tolerability of choline alphoscerate (cereton) in patients with Parkinson's disease with cognitive disorders].
    Levin OS; Batukaeva LA; Anikina MA; Iunishchenko NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(11):42-6. PubMed ID: 20032953
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Piracetam combined with lecithin in the treatment of Alzheimer's disease.
    Growdon JH; Corkin S; Huff FJ; Rosen TJ
    Neurobiol Aging; 1986; 7(4):269-76. PubMed ID: 3528889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders.
    Vernon MW; Sorkin EM
    Drugs Aging; 1991 Jan; 1(1):17-35. PubMed ID: 1794001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Piracetam in the treatment of post-concussional syndrome. A double-blind study.
    Hakkarainen H; Hakamies L
    Eur Neurol; 1978; 17(1):50-5. PubMed ID: 342247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin.
    Neznamov GG; Teleshova ES
    Neurosci Behav Physiol; 2009 Mar; 39(3):311-21. PubMed ID: 19234797
    [No Abstract]   [Full Text] [Related]  

  • 60. [Therapeutic use of piracetam in myocardial infarct patients].
    Leshchinskiĭ LA; Pimenov LT; Fedorov VS
    Kardiologiia; 1987 Feb; 27(2):46-50. PubMed ID: 3573522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.